TITLE

VeroPharm posts 2011 IFRS net profits of 1.8 bln rubles, up 42.5% (Part 2)

AUTHOR(S)
Interfax
PUB. DATE
May 2012
SOURCE
Russia & CIS Business & Financial Newswire;5/24/2012, p1
SOURCE TYPE
Newswire
DOC. TYPE
Article
ABSTRACT
MOSCOW. May 24 (Interfax) - Net profits at OJSC VeroPharm (RTS: VRPH) calculated to International Financial Reporting Standards (IFRS) increased 42.5% last year to 1.78 billion rubles, the company reported.
ACCESSION #
76123067

 

Related Articles

  • CONSENSUS: VeroPharm ups IFRS net profit 24% in 2011. Interfax // Russia & CIS Business & Financial Newswire;5/23/2012, p1 

    MOSCOW. May 23. (Interfax) - OJSC VeroPharm (RTS: VRPH) boosted its net profit to International Financial Reporting Standards (IFRS) 24% in 2011 to 1.5 billion rubles, analysts at investment companies and banks told Interfax in a consensus forecast.

  • VeroPharm posts 2011 IFRS net profits of 1.8 bln rubles, up 42.5%. Interfax // Russia & CIS Business & Financial Newswire;5/24/2012, p1 

    MOSCOW. May 24 (Interfax) - Net profits at OJSC VeroPharm (RTS: VRPH) calculated to International Financial Reporting Standards (IFRS) increased 42.5% last year to 1.78 billion rubles, the company reported.

  • VeroPharm IFRS net profits down 11% in H1. Interfax // Russia & CIS Business & Financial Newswire;8/29/2012, p1 

    MOSCOW. Aug 29 (Interfax) - OJSC VeroPharm (RTS: VRPH), one of Russia's biggest pharmaceuticals manufacturers, saw its net profits to International Financial Reporting Standards (IFRS) slide 11% year-on-year to 782.6 million rubles in the first half of 2012.

  • VeroPharm IFRS net profits down 11% in H1 (Part 2). Interfax // Russia & CIS Business & Financial Newswire;8/29/2012, p1 

    MOSCOW. Aug 29 (Interfax) - OJSC VeroPharm (RTS: VRPH), Russia's leading pharmaceuticals manufacturer, saw its net profits to International Financial Reporting Standards (IFRS) slide 11% year-on-year to 782.6 million rubles in the first half of 2012.

  • VeroPharm IFRS net profits fall 61.5% to 226 mln rubles in Q4. Interfax // Russia & CIS Business & Financial Newswire;4/30/2013, p1 

    MOSCOW. April 30 (Interfax) - OJSC VeroPharm's (RTS: VRPH) net profit to International Financial Reporting Standards (IFRS) slumped 61.5% to 226 million rubles in Q4 2012, the company reported.

  • VeroPharm IFRS net profits fall 61.5% to 226 mln rubles in Q4 (Part 2). Interfax // Russia & CIS Business & Financial Newswire;4/30/2013, p1 

    MOSCOW. April 30 (Interfax) - OJSC VeroPharm's (RTS: VRPH) net profit to International Financial Reporting Standards (IFRS) slumped 61.5% to 226 million rubles in Q4 2012, the company reported.

  • VeroPharm sees IFRS net profit fall 44% to 155.4 mln rubles in Q3. Interfax // Russia & CIS Business & Financial Newswire;11/30/2012, p1 

    MOSCOW. Nov 30 (Interfax) - OJSC VeroPharm (RTS: VRPH) saw its net profit to International Financial Reporting Standards (IFRS) fall 19% to 938 million rubles in January-September 2012 and 44% year-on-year to 155.4 million rubles in Q3 alone, according to the company's financial statement.

  • VeroPharm sees IFRS net profit fall 44% to 155.4 mln rubles in Q3 (Part 2). Interfax // Russia & CIS Business & Financial Newswire;11/30/2012, p1 

    MOSCOW. Nov 30 (Interfax) - OJSC VeroPharm (RTS: VRPH) saw its net profit to International Financial Reporting Standards (IFRS) fall 19% to 938 million rubles in January-September 2012 and 44% year-on-year to 155.4 million rubles in Q3 alone, according to the company's financial statement.

  • VeroPharm sees IFRS net profit fall 44% to 155.4 mln rubles in Q3 (Part 3). Interfax // Russia & CIS Business & Financial Newswire;11/30/2012, p1 

    MOSCOW. Nov 30 (Interfax) - OJSC VeroPharm (RTS: VRPH) saw its net profit to International Financial Reporting Standards (IFRS) fall 19% to 938 million rubles in January-September 2012 and 44% year-on-year to 155.4 million rubles in Q3 alone, according to the company's financial statement.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics